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http://dx.doi.org/10.1016/j.stemcr.2017.04.023SUMMARYMicroglia, the immune cells of the brain, are crucial to proper development and maintenance of the CNS, and their involvement in
numerous neurological disorders is increasingly being recognized. To improve our understanding of human microglial biology, we
devised a chemically defined protocol to generate human microglia from pluripotent stem cells. Myeloid progenitors expressing
CD14/CX3CR1 were generated within 30 days of differentiation from both embryonic and induced pluripotent stem cells (iPSCs).
Further differentiation of the progenitors resulted in ramified microglia with highly motile processes, expressing typical microglial
markers. Analyses of gene expression and cytokine release showed close similarities between iPSC-derived (iPSC-MG) andhumanprimary
microglia as well as clear distinctions frommacrophages. iPSC-MG were able to phagocytose and responded to ADP by producing intra-
cellular Ca2+ transients, whereas macrophages lacked such response. The differentiation protocol was highly reproducible across several
pluripotent stem cell lines.INTRODUCTION
Microglia are resident, tissue-specific macrophages that
perform several critical roles in development and mainte-
nance of the CNS (Hanisch and Kettenmann, 2007). They
arise from primitive CD45+CX3CR1 myeloid progenitors
in the yolk sac that differentiate to CD45+CX3CR1+ micro-
glial progenitors and invade the developing brain before
the emergence of definitive hematopoiesis (Ginhoux
et al., 2010; Kierdorf et al., 2013; Schulz et al., 2012). In
the healthy adult brain with an intact blood-brain barrier,
microglia persist as a self-sustained population that is not
replenished by circulating bone marrow-derived cells
(Ajami et al., 2007; Ginhoux et al., 2010). ‘‘Resting’’ micro-
glia are highly active as their processes continuously
examine the entire brain for homeostatic disruptions
(Nimmerjahn et al., 2005).
Microglia phagocytose pathogens and cell debris and re-
move toxic molecules and protein deposits, thus attenu-
ating inflammation and promoting tissue regeneration
and repair (Fenn et al., 2012; Napoli and Neumann,
2009). During development, microglia promotemigration
and differentiation of neural progenitors, neurogenesis,
and oligodendrogenesis, and regulate synaptogenesis
and synaptic plasticity through pruning (Aarum et al.,
2003; Paolicelli et al., 2011; Ueno et al., 2013). Microglia
can also contribute to pathological brain inflammation1516 Stem Cell Reports j Vol. 8 j 1516–1524 j June 6, 2017 j ª 2017 The Au
This is an open access article under the CC BY-NC-ND license (http://creativand disruption of the blood-brain barrier by releasing cy-
tokines and neurotoxic molecules (Colton and Gilbert,
1987; Luheshi et al., 2011). Dysfunctional microglia
have been linked to amyotrophic lateral sclerosis and
Alzheimer’s disease. Chronic activation of microglial cells
is a possible trigger to the progression of multiple sclerosis
and Parkinson’s disease (Kierdorf et al., 2013), and defec-
tive phagocytosis and synaptic pruning have been impli-
cated in schizophrenia and autism spectrum disorders
(Ransohoff, 2016).
Althoughmost of our knowledge regardingmicroglia de-
rives from rodent studies, there are major interspecies dif-
ferences, such as proliferation rate, adhesive properties,
and expression of critical receptors (Smith and Dragunow,
2014). The analysis of primary humanmicroglia is severely
limited by tissue availability, especially from healthy
individuals.
We developed a robust, reproducible protocol that
generates microglia from human pluripotent stem
cells (PSCs) in chemically defined conditions, by
mimicking embryonic development. Human induced
PSC (iPSC)-derived microglia (iPSC-MG) are similar by
morphology, gene expression, and cytokine release pro-
file to human primary microglia and are distinct from
other tissue macrophages. Furthermore, they are able
to phagocytose and generate intracellular Ca2+ tran-
sients in response to ADP.thor(s).
ecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. PSC Differentiate to Microglia through Myeloid Progenitors
(A) Diagram depicting the major steps of the microglial differentiation protocol.
(B) Kinetics of CD45, CX3CR1, and CD14 expression between day 10 and day 25 in the adherent and supernatant fractions.
See also Figure S1.RESULTS
Differentiation ofHumanPSCs toMyeloid Progenitors
As microglial cells arise from myeloid progenitors in the
yolk sac during development, we established a serum-
and feeder-free protocol to differentiate human PSCs
toward the myeloid lineage (Figure 1A). Building upon
previous studies (Yanagimachi et al., 2013), we induced
primitive streak-like cells through bone morphogenetic
protein 4 (BMP4) signaling to obtain KDR+CD235a+ prim-
itive hemangioblasts (Sturgeon et al., 2014) (Figure S1A).
CD45+CX3CR1 microglial progenitors appeared in the
supernatant by day 16, while CX3CR1 was upregulated
between days 20 and 25. In contrast, the adherent popula-tion contained only a small fraction of CD45+CX3CR1+
progenitors. Interestingly, CD14 was upregulated in a sub-
set of CD45+ cells around day 16, before the appearance of
CX3CR1 (Figure 1B). Between days 25 and 50, 82% ± 5% of
the CD14+ cells co-expressed CX3CR1. The protocol’s effi-
ciency to generate microglial progenitors, based on CD14
expression, was 68% ± 4% across 16 lines (Figure S1D).
Microglial progenitors were continuously generated in
the supernatant for up to 1 month and were isolated every
week with an average yield of 224 ± 423 103 cells per isola-
tion, per 100 3 103 PSCs plated. Microglial progenitors
were isolated either via fluorescence-activated cell sorting
(FACS) (Figures S1B and S1C) or magnetic bead separation
for further differentiation or long-term storage. ThawedStem Cell Reports j Vol. 8 j 1516–1524 j June 6, 2017 1517
Figure 2. Characterization of iPSC-MG
(A) Panel of representative images of iPSC-
MG in phase contrast and after immunofluo-
rescent labeling for IBA1, CD11c, TMEM119,
and P2RY12. White boxes indicate the areas
of the magnified insets. Scale bars, 50 mm
(phase contrast) and 200 mm (all other
images).
(B) Representative flow-cytometry plots
for typical microglial surface antigens in
iPSC-MG.
(C) Dot plot showing the percentage of total
cells expressing the microglial surface anti-
gens shown in (B) across four independent
iPSC-MG (depicted as circles) and two hMG
samples (depicted as triangles). Error bars
denote mean ± SEM.
See also Movie S1 and Figure S2 for charac-
terization of hMG.progenitors retained their differentiation capacity, with a
post-thaw viability of 57% ± 5%.
iPSC-MG Express Typical Microglial Markers and
Show Highly Motile Processes
Interleukin-34 (IL-34) and granulocyte macrophage col-
ony-stimulating factor (GM-CSF) stimulation (Ohgidani
et al., 2014) of plated microglial progenitors resulted in
iPSC-MG, extending highly motile processes, constantly
scanning the microenvironment (Movie S1), similarly to
microglia in vivo (Davalos et al., 2005; Nimmerjahn,
2012). iPSC-MG expressed known markers such as IBA1,
CD11c, TMEM119, P2RY12, CD11b, and CX3CR1 (Figures
2A–2C). Fetal human primary microglia (hMG) were used
for comparison (Figure S2).
iPSC-MGResembleHumanPrimaryMicroglia byGene
Expression
To further support the microglial identity of iPSC-MG,
we performed whole-transcriptome analysis with next-
generation deep RNA sequencing (RNA-seq). iPSC-MG
from six unrelated healthy donors were compared with
peripheral blood-derived macrophages (PB-M()) or polar-
ized to M(lipopolysaccharide [LPS], interferon g [IFNg]),
M(IL-4,IL-13), and M(IL-10), primary human hepatic mac-1518 Stem Cell Reports j Vol. 8 j 1516–1524 j June 6, 2017rophages (hhM), and primary humanmicroglia cultured in
serum-containingmedium supplied by the provider (hMG)
or in our serum-free medium (hMG-SF). We obtained high-
quality reads (mean Phred quality score >38.4) and 86.2%
mapped to the human genome; 18,516 genes were con-
sidered expressed and used for analysis.
iPSC-MG, hMG, and hMG-SF clustered together in a hier-
archical cluster analysis using all the expressed genes
showing a high degree of similarity (Spearman’s correlation
coefficient 0.901–0.997) and were distinct from all macro-
phage subtypes (Figure 3A). When we included data ob-
tained from an independent study (Zhang et al., 2016)
that isolated primary CD45+ cells from human brain ex-
tracts (termed ‘‘Myeloid’’ in Figure 3B), iPSC-MG samples
clustered together with the ‘‘Myeloid’’ samples, while
PB-M created a distinct cluster and hhM clustered sepa-
rately, appearing the most dissimilar.
Three recent studies (Bennett et al., 2016; Butovsky et al.,
2014; Hickman et al., 2013) provided datasets with unique
genes expressed inmicroglia from primary rodent cells. We
selected genes that were identified in at least two of these
studies and assessed their expression in our samples (Table
S1). Of the 31 selected genes, 29 were expressed (at least
1 cpm) by hMG and 28 by iPSC-MG. Overall, their ex-
pression was comparable with the exception of P2RY13
(legend on next page)
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(2.6-fold lower in iPSC-MG) and CYSLTR1 (3.8-fold lower
in hMG).Moreover, LIPHhad very low expression in all hu-
man cell types, while hMG showed low expression of
CX3CR1, and iPSC-MG low expression of TMEM119 and
LAG3. However, CX3CR1 and TMEM119 proteins were
detected by FACS and immunofluorescent staining,
respectively.
Comparison with hhM and PB-M() highlighted 11
genes that were consistently higher in both iPSC-MG and
hMG (shown in red in Table S1).
Butovsky et al. proposed six genes, namely C1QA, GAS6,
GPR34, MERTK, P2RY12, and PROS1, as unique signature
in human primarymicroglia. Indeed, their high expression
was consistent among all ourmicroglial samples (iPSC-MG,
hMG,hMG-SF) aswell as inhumanmicroglial samples from
two independent studies (Muffat et al., 2016; Zhang et al.,
2016) (Figure 3C), whereas macrophages and neural pro-
genitor cells (NPCs) showed lower levels (t test: p < 0.05
for microglia versus macrophages or NPCs in all six genes).
Cytokine Profiles ofHuman iPSC-Derived andPrimary
Microglia Are Similar, but Differ from Peripheral
Blood-Derived Macrophages
We analyzed the proteins released by iPSC-MG, hMG,
hMG-SF, and PB-M, including differentially polarized mac-
rophages (Figure 3D). Interestingly, similarities between
iPSC-MG and primary microglia drastically increased
when hMG were cultured in our differentiation medium
(hMG-SF), as Pearson’s correlation coefficient increased
from r = 0.473 to r = 0.824. Of note, hMG showed upregu-
lation of cytokines, such as RANTES, I-TAC, BAFF, GR0-a,
and MIP3a, which are typically released upon inflamma-
tion, and in fact were also expressed by M(LPS,IFNg)
macrophages (red arrows in Figure 3D). Nevertheless,
microglial samples clustered together and away from all
PB-M subtypes.
iPSC-MG Are Functional Phagocytes
iPSC-MG, hMG, hMG-SF, PB-M, and undifferentiated iPSCs
were challenged with a given amount of fluorescentlyFigure 3. Gene Expression, Cytokine Release Profile, and Phagocy
(A) Hierarchical clustering dendrogram of the RNA-seq data based o
Pearson’s correlation coefficient.
(B) Dendrogram showing hierarchical clustering of our RNA-seq data
CD45+ cells in the brain (‘‘Myeloid’’ samples in red, GEO: GSE73721). A
(C) Graphs showing the expression levels of the six human microg
correspond to data from independent studies (GEO: GSE73721 in red;
(D) Heatmap of the released cytokine profiles of five independent iPS
hMG-SF sample compared with PB-M. Red arrows indicate the five pro
(E) Representative fluorescent image and flow-cytometry histograms
Scale bar, 200 mm. iPSC, undifferentiated iPSCs used as negative con
See also Figure S3; Tables S1 and S2.
1520 Stem Cell Reports j Vol. 8 j 1516–1524 j June 6, 2017labeled latex microspheres per cell. Flow-cytometry anal-
ysis showed that the majority of iPSC-MG were able to
phagocytose (90% ± 6%) as were both hMG and hMG-SF.
As expected, PB-M() macrophages were also able to
engulf microspheres while undifferentiated iPSCs were
not (Figure 3E).iPSC-MGRelease Intracellular Ca2+ inResponse to ADP
Themicroglial signature gene P2RY12 encodes a GI protein-
coupled receptor (Haynes et al., 2006) that responds to ADP,
resulting in intracellular Ca2+ ([Ca2+]i) transients, whereas
PB-M that lack P2RY12 expression do not respond to ADP
(Moore et al., 2015). Thus, ADP-induced [Ca2+]i transients
can be used to differentiate between microglia and macro-
phages. When we stimulated iPSC-MG, hMG, hMG-SF,
and PB-Mwith ADP, onlymicroglial cells responded (Figures
4A–4C). The peak amplitude of ADP responses in iPSC-MG
(Figure 4E) as well as the number of responsive cells (Fig-
ure 4F) were higher than either hMG or hMG-SF. On the
contrary, none of the differentially polarized PB-M res-
ponded to ADP, but [Ca2+]i transients were reliably observed
upon stimulation with ATP (Figures 4D and S4).DISCUSSION
As in vitro hematopoietic differentiation of PSCs resembles
in vivo primitive hematopoiesis rather than definitive he-
matopoiesis (Vanhee et al., 2015), we reasoned that PSC-
derived myeloid progenitors would resemble in vivo prim-
itive yolk sacmyeloid progenitors, and therefore could give
rise to microglia in vitro. Stimulating PSCs with a myeloid
inductive medium followed by treatment with microglia-
promoting cytokines generated KDR+CD235a+ primitive
hemangioblasts, which subsequently transitioned from
CD45+CX3CR1 to CD45+CX3CR1+ microglial progeni-
tors in vitro.
To ensure robustness and reproducibility of the protocol,
we tested a panel of 16 PSC lines (Table S3) including iPSCs
from individuals with varying disease status, age, and sex,tosis of Microglia and Macrophages
n global mRNA expression. Sample distances were calculated from
and data obtained from an independent study of human primary
nalysis is based on transcriptome-wide expression.
lial signature genes. Error bars are means ± SD. Colored samples
GEO: GSE85839 in blue).
C-MG runs from two lines, two independent hMG samples, and one
teins upregulated in hMG and M(LPS,IFNg).
showing phagocytosis of yellow-green (YG)-labeled microspheres.
trol.
Figure 4. ADP-Evoked [Ca2+]i Transients
in Microglia and Macrophages
(A) Left panel shows five example traces of
[Ca2+]i transients following ADP application
in iPSC-MG loaded with the Ca2+ indicator
Fluo-4/AM. Right panel shows time lapse of
changes in fluorescence intensity produced
by ADP application. Magenta and cyan
traces originate from cells indicated by
same-colored regions of interest in the
right panel. Bars represent duration of ADP
or ATP application.
(B and C) Same data as in (A), obtained from
primary human microglia (hMG) and hMG-SF
correspondingly.
(D) ADP and ATP responses in PB-M().
Note the absence of significant [Ca2+]i
transients in response to ADP.
(E) Statistical analysis for the amplitudes of
[Ca2+]i transients. Maximum amplitude of
[Ca2+]i transient for each responsive cell is
presented as a gray dot in the correspond-
ing category (***p < 0.001 by t test).
(F) Percentages of ADP-responsive cells
among all different cell types analyzed.
Ratios for each cell type indicate the num-
ber of responsive cells out of total number
of cells analyzed. iPSC-MG data are pooled
from three independent experiments.
See also Figure S4.generated using different reprogramming strategies (e.g.,
mRNA/microRNA, Sendai virus). We were able to obtain
microglial progenitors from all lines, with an average yield
of two to three progenitors per undifferentiated PSC. The
yield of progenitors varied across the lines without correla-
tion to a specific disease, reprogramming method, or sex
and age of the donor. The resulting microglia expressed
typical markers, were ramified with highly motile pro-
cesses, and were able to phagocytose with efficiency equiv-
alent to that of human primary microglia.
While the identity of humanmicroglia has not been well
established, recent genome-wide studies in mouse have
provided datasets to facilitate the distinction of microglia
from other myeloid or CNS cell types (Bennett et al.,
2016; Butovsky et al., 2014; Hickman et al., 2013). There-
fore, we compared global mRNA expression of iPSC-MG
with primary microglia and both peripheral blood-derivedand hepatic macrophages to evaluate the proposed ‘‘signa-
ture genes’’ in human microglia. As obtaining all these cell
types from the same individual was not feasible, we
included samples with different genetic backgrounds,
which may increase the ‘‘noise’’ of the data and possibly
mask differences between cell types. However, our analyses
clearly showed that iPSC-MG were clustered away from
both circulating and other tissue-specific macrophages,
and together with primary microglia and CD45+ cells
(called ‘‘myeloid’’), isolated from human brains (Zhang
et al., 2016). Furthermore, iPSC-MG expressed the six genes
suggested as unique to human microglia (Butovsky et al.,
2014) and many other genes enriched in mouse microglia
(Table S1).
The cytokine profile of microglia was distinct from PB-M,
independent of polarization status. iPSC-MG clustered
together with hMG and tighter when hMG were culturedStem Cell Reports j Vol. 8 j 1516–1524 j June 6, 2017 1521
in our medium (hMG-SF), probably due to the absence of
serum. In vivo, microglia reside behind the blood-brain
barrier, and the presence of serum components triggers
their activation (Ransohoff and Perry, 2009). Indeed,
hMG cultured in serum showed increased levels of inflam-
matory molecules such as RANTES, GR0-A, I-TAC, BAFF,
and MIP3a, similarly to M(LPS,IFNg) pro-inflammatory
macrophages.
Finally, we showed that iPSC-MG express functional
P2RY12 at both transcript and protein levels. This receptor
distinguishes rodent and human microglia from other
myeloid cells (Butovsky et al., 2014) and its activation via
ADP results in [Ca2+]i transients (Moore et al., 2015). All
microglial samples (iPSC-MG, hMG, and hMG-SF) showed
ADP-evoked [Ca2+]i transients, while PB-M were unrespon-
sive to ADP but showed [Ca2+]i upon exposure to ATP, indi-
cating that they were healthy and functional.
While this manuscript was under review, Muffat et al.
(2016) published a microglial differentiation protocol, and
we are providing a comparisonwith their RNA-seq data (Fig-
ures 3C and S3). Both approaches mimic embryonic devel-
opment (derived via CD235a+ yolk sac progenitors), use
IL-34 as the main driver to microglial lineage commitment
and maturation in chemically defined media, and generate
microglia with motile processes that express typical makers
and are able to performphagocytosis. Our strategy, based on
monolayer cultures instead of embryoid bodies (EBs), is
comparable in efficiency but requires fewer starting PSCs.
Importantly, our protocol does not requiremanual selection
of specific EBs.We isolatemicroglial progenitors via FACS or
magnetic beads, enabling high-throughput applications
such as compound and genetic screens.
While the global expression profile of iPSC-MG strongly
resembles that of human primary microglia, discrepancies
were found for some microglia markers including
TMEM119, LAG3, and CX3CR1. Surprisingly, mRNA levels
of TMEM119 were very low in iPSC-MG compared with
hMG, even though the protein was detected by immuno-
fluorescence. TMEM119 mRNA levels in the study by
Muffat et al. (2016) were variable across different iPSC
lines and there was a trend for downregulation when cells
were cultured in ‘‘NPC-conditioned medium.’’ Another
recent differentiation protocol (Pandya et al., 2017)
describes the generation of iPSC-derived microglia from
hematopoietic progenitors but requires astrocyte co-cul-
ture in the presence of serum. Under these experimental
conditions, microglia differentiation is accomplished
within 4 weeks with a yield comparable with both our
and the Muffat protocols. Although their gene expression
analysis was performed using microarrays, limiting direct
comparison of expression data, TMEM119 was also not
highly expressed and not significantly different from
iPSC or fetal MG expression in their dataset. On the other1522 Stem Cell Reports j Vol. 8 j 1516–1524 j June 6, 2017hand, serum exposure upregulated TMEM119 in our hMG,
suggesting that culture environment can alter expression.
As studies in rodents suggest that Tmem119 is develop-
mentally regulated (Bennett et al., 2016), variable expres-
sion could also reflect immaturity. In addition, minimal
levels of LAG3 mRNA were detected in human primary
and iPSC-derived microglia, unless they were exposed to
either ‘‘NPC-conditioned medium’’ (in Muffat et al.,
2016) or serum, despite previous studies in rodents (Butov-
sky et al., 2014; Hickman et al., 2013) that identified Lag3
as a key microglial gene. As microglia are particularly sen-
sitive to exogenous stimuli, different culture conditions
are likely responsible for the subtle discrepancies in
transcript levels observed between different protocols.
Furthermore, microglia are known to express the chemo-
kine receptor CX3CR1 early in development, and it was
detected by flow cytometry in both hMG and iPSC-MG
derived through our protocol and from Pandya et al.
(2017). In contrast, mRNA was not considered expressed
in human primary microglia (Muffat et al., 2016 and our
study) or iPSC-derived microglia (Muffat et al., 2016) and
varied in our iPSC-MG. Transcript levels of CX3CR1 were
also relatively low and variable in the Pandya et al.
(2017) study despite detectable protein expression by
FACS. Further work will be needed to address these
discrepancies and distinguish culture-related regulation
from developmental regulation of markers.
Overall, our protocol provides iPSC-MG as a new source
of human microglial cells, which will complement studies
in mouse models to better understand the role of microglia
in health and disease. We have shown that the protocol is
highly reproducible, andwe anticipate that it will become a
critical tool to investigate microglial dysfunction in CNS
disorders. The inclusion of microglia in co-culture or
three-dimensional systems, involving iPSC-derived neu-
rons and other glial cell types, will be crucial to advance
in vitro disease modeling and better recapitulate the
complexity of the in vivo environment.EXPERIMENTAL PROCEDURES
Pluripotent Stem Cell Lines
Two human embryonic stem cell lines (RUES1 and H9, both NIH
approved) and 13 iPSC lines reprogrammed at New York Stem
Cell Foundation upon institutional review board approvals and
informed consent and one iPSC line from Dr. Ricardo Feldman
were used in this study (Supplemental Experimental Procedures
and Table S3). Humanprimarymicroglia and hepaticmacrophages
were purchased from ScienCell Research Laboratories.Microglial Differentiation Protocol
PSC differentiation was induced with mTeSR Custom medium
(STEMCELLTechnologies)containing80ng/mLBMP4.Atday4cells
were induced with 25 ng/mL basic fibroblast growth factor,
100ng/mL stemcell factor (SCF), and80ng/mLvascular endothelial
growth factor in StemPro-34 SFM (with 2 mM GutaMAX, Life
Technologies). Two days later, the medium was supplemented
with 50 ng/mL SCF, 50 ng/mL IL-3, 5 ng/mL thrombopoietin,
50 ng/mL macrophage CSF (M-CSF) and 50 ng/mL Flt3l, and from
day 14 with 50 ng/mL M-CSF, 50 ng/mL Flt3l, and 25 ng/mL GM-
CSF.Betweendays25and50,CD14+orCD14+CX3CR1+progenitors
were isolated and plated onto tissue culture-treated dishes or
Thermanox plastic coverslips (all from Thermo Fisher Scientific) in
Microglial Medium (RPMI-1640 [Life Technologies] with 2 mM
GlutaMAX-I, 10 ng/mL GM-CSF, and 100 ng/mL IL-34). Medium
was replenished every 3–4 days for at least 2 weeks.
Other experimental procedures are described in the Supple-
mental Experimental Procedures.
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